A study from the Scripps Institute demonstrated that fisetin eliminated up to 50% of senescent cells in aged mice, restoring tissue function. Another at Mayo Clinic showed that the dasatinib+quercetin combination reduced senescent burden in humans with pulmonary fibrosis. We are witnessing the first generation of natural senolytics that have arrived in biohacking from academic research on ageing.
But here comes the problem: the internet is full of exaggerated claims ('cures ageing'), arbitrary doses and confusion about when to take them. The reality is more nuanced: senolytics work under specific conditions, with intermittent protocols, and they're not for everyone.
In this article you'll learn exactly what a senolytic does in your body, how quercetin and fisetin compare in mechanism and evidence, the doses used in clinical studies, and—crucially—when NOT to take them. All with references to real studies, without marketing.
Senolytics are not taken every day. They are intermittent protocols designed to clear zombie cells without interfering with normal repair processes.
What you need to know
- What they are: compounds that selectively eliminate senescent cells (aged but not dead) that accumulate inflammation
- Mechanism: inhibit anti-apoptotic pathways (BCL-2, PI3K/AKT) that keep these zombie cells alive
- Fisetin vs quercetin: fisetin more potent in animal models but less bioavailable; quercetin has more human studies
- Clinical dose: fisetin 1000–1500mg x 2 consecutive days/month; quercetin 1000mg + dasatinib (prescription only)
- When NOT to take them: pregnancy, active cancer treatment, before surgery, without consulting a doctor
- Natural sources: quercetin in red onions, apples; fisetin in strawberries (but you'd need kilograms for clinical dose)
What are senolytics and why they matter
A senolytic is a compound that induces apoptosis (programmed cell death) selectively in senescent cells.
Senescent cells are cells that have stopped dividing but don't die. They remain metabolically active and secrete inflammatory factors—the famous SASP (senescence-associated secretory phenotype)—that accelerate tissue deterioration, insulin resistance, sarcopenia and vascular dysfunction.
The problem isn't having senescent cells (they're needed for wound healing and development), but their progressive accumulation with age. Meta-analyses in Nature Aging show that eliminating these cells in animal models extends healthspan and reverses frailty markers.
Senolytics are not conventional antioxidants or anti-inflammatories. They are molecular switches that force these zombie cells to self-destruct, clearing space for regeneration.
How they work at the molecular level
Senescent cells avoid apoptosis by activating pro-life survival pathways: BCL-2, BCL-xL, BCL-W (anti-apoptotic protein family) and PI3K/AKT (growth signalling).
Senolytics inhibit these pathways simultaneously:
Quercetin acts mainly on PI3K/AKT and serpins (apoptosis inhibitors). Fisetin additionally modulates mTOR (nutrient sensor) and has direct effect on BCL-2.
Studies in Cell Metabolism demonstrated that dasatinib (leukaemia drug) + quercetin is synergistic because they attack complementary pathways: dasatinib targets senescent endothelial cells/adipocytes, quercetin targets immune system/fibroblasts.
Quercetin: the most-studied senolytic in humans
Quercetin is a flavonoid found in red onions, apples, green tea, capers. In supplementation, anhydrous form or quercetin dihydrate is used.
Clinical evidence
The AFFIRM-AHF study (European Heart Journal) evaluated quercetin in 100 patients with heart failure. Result: reduction of inflammatory markers (IL-6, TNF-α) but no impact on mortality at 6 months.
Another trial in Mayo Clinic Proceedings used dasatinib (100mg) + quercetin (1000mg) for 3 consecutive days in patients with idiopathic pulmonary fibrosis. It reduced senescent cells in adipose tissue by 36% and improved physical function (6-minute walk test).
Bioavailability: the Achilles heel
Oral quercetin has bioavailability of 2–20% depending on formulation. Quercetin phytosome form (bound to phosphatidylcholine) multiplies absorption x20 according to pharmacokinetic studies.
Clinical dose: 500–1000mg/day in continuous use as an antioxidant; 1000mg x 2–3 consecutive days in intermittent senolytic protocol.
Food sources
Red onion: ~50mg/100g. You'd need 2kg of onion for senolytic dose. Apples with skin provide ~10mg/fruit. It's impossible to reach therapeutic dose from diet alone.
Fisetin: more potent but less studied
Fisetin is a flavonol from strawberries, apples, persimmons, cucumbers. In animal models it's the most effective natural senolytic according to screening from the Scripps Research Institute.
Robust pre-clinical evidence
A study in Nature Medicine: fisetin (100mg/kg for 5 days) in aged mice eliminated senescent cells in kidney, visceral fat and liver, extending lifespan by 10% and improving heart function.
Another in Aging Cell demonstrated that fisetin restores cognitive function in mice with Alzheimer's by reducing neuroinflammation mediated by senescence.
Human studies: still limited
A pilot trial at Mayo Clinic (2020) evaluated fisetin (20mg/kg/day x 2 consecutive days/month for 2 months) in 40 people >60 years. It was well tolerated but the study ended early due to COVID. Preliminary results showed trend toward reduction in SASP markers but without statistical significance due to sample size.
Critical bioavailability
Fisetin has oral bioavailability of <10% (worse than quercetin). Pharmacokinetic studies show that liposomal formulations or those with piperine (BioPerine) improve absorption x5–7.
Emerging clinical dose: 1000–1500mg (equivalent ~20mg/kg for 70kg person) x 2 consecutive days every 4–6 weeks.
Food sources
Strawberry: ~160μg/g fresh weight. You'd need 6kg of strawberries for a 1g senolytic dose. Persimmons have similar concentration. Supplementation is the only practical route.
Direct comparison: which to choose
Quercetin: more human studies, established safety profile, bioavailability improvable with phytosomes. Ideal if you seek senolytic with clinical track record.
Fisetin: more potent in animal models, fewer human data, problematic bioavailability. Option if you prioritise theoretical potency and accept less certainty.
Dasatinib+quercetin combination: the gold standard in clinical research but dasatinib is a prescription drug (tyrosine kinase inhibitor). Don't try it on your own.
Intermittent protocols: key to success
Senolytics are NOT taken every day. The typical protocol is 2–3 consecutive days every 4–6 weeks. Why?
- You avoid interfering with transient senescence needed for post-exercise or post-infection tissue repair
- You reduce risk of cumulative side effects
- You give your immune system time to clear cellular debris
Meta-analyses in Ageing Research Reviews conclude that intermittent pulses are more effective and safer than chronic dosing.
Recommended doses according to current evidence
Quercetin
- Senolytic protocol: 1000mg/day x 2 consecutive days, repeat every 4–6 weeks
- Continuous antioxidant use: 250–500mg/day (different aim, not senolytic)
- With dasatinib (under medical supervision): quercetin 1000mg + dasatinib 100mg x 3 days
Fisetin
- Emerging protocol: 1000–1500mg/day x 2 consecutive days, every 4–6 weeks
- Formulation: prioritise liposomal or with BioPerine for bioavailability
- Timing: with fat-rich meal for absorption (fisetin is lipophilic)
How to choose a quality senolytic
Most quercetin and fisetin supplements on Amazon have sub-therapeutic doses (100–250mg) because it's cheaper to manufacture.
Quality criteria:
- Real clinical dose: minimum 500mg quercetin, 500–1000mg fisetin per capsule
- Bioavailable formulation: quercetin phytosome or with bromelain; fisetin liposomal or with piperine
- GMP certification: guarantee of purity and absence of heavy metals
- Transparency: label with exact mg, not '10:1 extract' that hides dose
- No unnecessary fillers: magnesium stearate, titanium dioxide, dyes
At Longevitalis we've developed 3 complementary protocols—LongeviNocturno for nocturnal repair, Vitalis Renova+ for morning cellular renewal (includes bioavailable quercetin at clinical dose alongside NAD+ precursors), and LongeviSkin for skin from within. All with clinical doses based on studies, formulated in Spain under GMP, without fillers.
We don't sell magic or marketing anti-ageing. We sell evidence-backed protocols that fit into your real life.
Side effects and contraindications
Quercetin
Well tolerated in studies up to 1000mg/day x 12 weeks. Occasional mild effects: headache, gastric discomfort (take with food).
Drug interactions:
- May potentiate anticoagulants (warfarin, heparin)
- Interferes with some antibiotics (fluoroquinolones)
- Inhibits cytochrome P450 (may alter drug metabolism)
Fisetin
Safety data in humans still limited. Pilot studies reported no serious adverse events at 20mg/kg x 2 days.
Theoretical precaution: as a potent senolytic could interfere with acute tissue repair (post-surgery, fractures).
Absolute contraindications
- Pregnancy and breastfeeding: zero safety data
- Active cancer treatment: senolytics could interfere with chemo/radiotherapy (consult oncologist)
- Pre/post-surgery: discontinue 2 weeks before and after
- Coagulation disorders: bleeding risk with quercetin
Natural senolytics: beyond quercetin and fisetin
Other compounds with emerging senolytic activity:
Curcumin: inhibits NF-κB (inflammation factor) and reduces SASP. Terrible bioavailability (<5%) without special formulation.
Epigallocatechin gallate (EGCG) from green tea: in vitro studies show selective elimination of senescent cells in fibroblasts. Effective dose ~400–800mg standardised extract.
Piperlonguminine (piperine): very preliminary research in senescent cancer cells. Zero human studies.
Luteolin: flavonoid with moderate senolytic effect in cellular models. Present in celery, parsley, thyme.
None have the volume of evidence of quercetin or fisetin. If you experiment, prioritise the 2 protagonists of this article.
Frequently asked questions
Can I take quercetin and fisetin together?
No combination studies exist. Theoretically they're synergistic (complementary mechanisms) but you'd also double risk of side effects. The dasatinib+quercetin protocol works because they attack different cell types. If you experiment, alternate: one month quercetin, next fisetin.
Do senolytics interfere with exercise?
Potentially yes. Post-exercise transient senescence is needed for muscle adaptation (hypertrophy, endurance). Don't take senolytics within 72 hours after intense training. The monthly intermittent protocol minimises this conflict.
At what age does it make sense to start?
Senescent burden starts accumulating significantly after 40–45 years. Before that, your immune system (immune surveillance) efficiently clears senescent cells. No evidence of benefit in <40 except specific medical conditions (metabolic syndrome, kidney disease).
Do senolytics from onions or strawberries work?
Not at relevant doses. A large red onion (~150g) provides ~75mg quercetin. You'd need 13 onions for 1g senolytic dose. Strawberries have even less fisetin. Eat them for their other benefits, not as senolytic.
How long before they take effect?
SASP markers (IL-6, TNF-α) drop in 1–2 weeks according to studies. Functional benefits (physical function, metabolic markers) appear at 4–12 weeks with intermittent protocols. Don't expect overnight changes.
Can I take them with other longevity supplements?
Yes, but with strategic timing. Separating from /en/creatine-monohydrate-guide and /en/omega-3-epa-dha-guide isn't necessary (independent mechanisms). Avoid combining with megadose antioxidants (may block apoptosis you're trying to induce).
Conclusion: senolytics with intelligence
Natural senolytics like quercetin and fisetin represent the first wave of anti-ageing interventions with human studies beyond exercise, caloric restriction and metformin.
But they're not magic pills. They work in context: intermittent protocols, clinical doses, bioavailable formulations, integrated into a lifestyle that minimises new senescent cell generation (sleep, exercise, anti-inflammatory diet).
The most robust evidence is in quercetin combined with dasatinib under medical supervision for specific conditions (fibrosis, kidney disease, frailty). Fisetin has greater potential but needs more human studies.
If you decide to experiment:
- Consult your doctor (especially if you take medication)
- Use real clinical doses, not the 100mg symbolic doses of cheap products
- Intermittent protocol (2 days/month), never continuous
- Monitor markers (inflammation blood tests every 3–6 months)
- Combine with habits that reduce senescence: /en/deep-sleep-guide, regular exercise, avoid ultra-processed foods
Senolytics don't replace the basics. They are layer 3 of a longevity protocol after sleep, nutrition and movement. Use them with that perspective.
Disclaimer: This information is for educational purposes and does not replace professional medical advice. Consult your doctor before starting any senolytic protocol, especially if you take anticoagulant medication, have pre-existing conditions or are undergoing cancer treatment. Food supplements should not be used as a substitute for a balanced diet.
